Ir directamente a la navegación principal
Ir directamente a la búsqueda
Ir directamente al contenido principal
Clasificar por
Immunology and Microbiology
Infection
100%
Infectious Disease
99%
In Vitro
63%
Minimum Inhibitory Concentration
36%
Susceptibility
33%
Antifungal Susceptibility
32%
Infectious Agent
24%
Aspergillus
23%
Candida Albicans
21%
Mould
18%
Candida
17%
Morphology
16%
Lung
15%
Candida Auris
15%
Aspergillosis
14%
Aspergillus fumigatus
14%
Fusarium
14%
New Species
14%
Antifungal Resistance
13%
Coccidioides
12%
Immunocompromised Patient
11%
Antifungal Activity
11%
Cladistics
10%
Fusarium solani
10%
Pharmacodynamics
10%
Broth Dilution
9%
Terbinafine
9%
Biofilm
9%
Filamentous Fungus
9%
Sterol
8%
Candida Glabrata
8%
Drug Megadose
8%
Cryptococcus neoformans
7%
DNA Sequence
7%
Epidemiology
6%
Cohort Effect
6%
Scedosporium
6%
Rhizopus oryzae
6%
Fungi
6%
Species Identification
6%
Morbidity
5%
Mucorales
5%
Fusarium oxysporum
5%
Keratitis
5%
Cryptococcus gattii
5%
Experimental Model
5%
Chronic Granulomatous Disease
5%
Filobasidiella
5%
Ascomycota
5%
Dermatophyte
5%
Pharmacology, Toxicology and Pharmaceutical Science
Echinocandin
34%
Infection
30%
Antifungal Agent
25%
Voriconazole
24%
Candida
22%
Amphotericin B
21%
Fluconazole
20%
Aspergillus
19%
Mycosis
17%
Pyrrole
17%
Candida Albicans
17%
Caspofungin
16%
Invasive Aspergillosis
16%
Posaconazole
16%
Candida glabrata
16%
Pharmacodynamics
15%
Invasive Candidiasis
15%
Pharmacokinetics
15%
Itraconazole
14%
Isavuconazole
14%
Systemic Mycosis
13%
Pyrrole Derivative
11%
Mucormycosis
10%
Resistance to Antifungal Agent
10%
Triazole
10%
Coccidioidomycosis
10%
Aspergillus fumigatus
9%
Coccidioides
8%
Rezafungin
8%
Mould
8%
Polyenes
8%
Infectious Agent
7%
Diseases
7%
Micafungin
7%
Antifungal Activity
7%
Placebo
6%
Anidulafungin
6%
Ibrexafungerp
6%
Candida Auris
6%
Fusarium
6%
Antiinfective Agent
6%
Repurposing
5%
Rhizopus arrhizus
5%
Candidiasis
5%
Minimum Inhibitory Concentration
5%
Glucan
5%
Olorofim
5%
Mucorales
5%
Coccidioides Immitis
5%
Tetrazole Derivative
5%
